# Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy

> **NCT02354781** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jerry R. Mendell** · enrollment: 3 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **BIOLOGICAL:** rAAV1.CMV.huFollistin344

## Key facts

- **NCT ID:** NCT02354781
- **Lead sponsor:** Jerry R. Mendell
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354781, "Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02354781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*